Medigen Vaccine Biologics Statistics

Total Valuation

TPEX:6547 has a market cap or net worth of TWD 16.04 billion. The enterprise value is 14.47 billion.

Market Cap	16.04B
Enterprise Value	14.47B

Important Dates

The next estimated earnings date is Monday, May 5, 2025.

Earnings Date	May 5, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6547 has 328.75 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	n/a
Shares Outstanding	328.75M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	3.23%
Float	251.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	37.83
PS Ratio	26.49
PB Ratio	4.17
P/TBV Ratio	4.20
P/FCF Ratio	2,484.97
P/OCF Ratio	393.66
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-179.78
EV / Sales	23.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2,240.75

Financial Position

The company has a current ratio of 11.94, with a Debt / Equity ratio of 0.09.

Current Ratio	11.94
Quick Ratio	9.54
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	52.50
Interest Coverage	-7.71

Financial Efficiency

Return on equity (ROE) is -2.09% and return on invested capital (ROIC) is -1.82%.

Return on Equity (ROE)	-2.09%
Return on Assets (ROA)	-1.74%
Return on Invested Capital (ROIC)	-1.82%
Return on Capital Employed (ROCE)	-3.51%
Revenue Per Employee	5.88M
Profits Per Employee	-781,214
Employee Count	103
Asset Turnover	0.12
Inventory Turnover	0.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.98% in the last 52 weeks. The beta is 1.09, so TPEX:6547's price volatility has been similar to the market average.

Beta (5Y)	1.09
52-Week Price Change	-2.98%
50-Day Moving Average	48.81
200-Day Moving Average	45.38
Relative Strength Index (RSI)	52.45
Average Volume (20 Days)	2,181,922

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6547 had revenue of TWD 605.64 million and -80.47 million in losses. Loss per share was -0.24.

Revenue	605.64M
Gross Profit	396.42M
Operating Income	-145.67M
Pretax Income	-80.47M
Net Income	-80.47M
EBITDA	-26.16M
EBIT	-145.67M
Loss Per Share	-0.24

Full Income Statement

Balance Sheet

The company has 1.92 billion in cash and 338.96 million in debt, giving a net cash position of 1.58 billion or 4.80 per share.

Cash & Cash Equivalents	1.92B
Total Debt	338.96M
Net Cash	1.58B
Net Cash Per Share	4.80
Equity (Book Value)	3.85B
Book Value Per Share	11.71
Working Capital	2.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 40.75 million and capital expenditures -34.30 million, giving a free cash flow of 6.46 million.

Operating Cash Flow	40.75M
Capital Expenditures	-34.30M
Free Cash Flow	6.46M
FCF Per Share	0.02

Full Cash Flow Statement

Margins

Gross margin is 65.46%, with operating and profit margins of -24.05% and -13.29%.

Gross Margin	65.46%
Operating Margin	-24.05%
Pretax Margin	-13.29%
Profit Margin	-13.29%
EBITDA Margin	-4.32%
EBIT Margin	-24.05%
FCF Margin	1.07%

Dividends & Yields

TPEX:6547 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	-0.50%
FCF Yield	0.04%

Stock Splits

The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.

Last Split Date	Aug 3, 2022
Split Type	Forward
Split Ratio	1.48280574

Scores

TPEX:6547 has an Altman Z-Score of 19.79.

Altman Z-Score	19.79
Piotroski F-Score	n/a